Labcorp assumed with a Buy at Jefferies

Jefferies assumed coverage of Labcorp (LH) with a Buy rating with a price target of $275, up from $265. Larger full-service reference labs, such as Labcorp, stand to benefit from the same tailwinds as “esoteric labs,” but with less idiosyncratic National Provider Identifier commercialization and reimbursement risk, the analyst tells investors.